TY - JOUR
T1 - Non-invasive electrical stimulation of peripheral nerves for the management of tremor
AU - Pascual-Valdunciel, Alejandro
AU - Rajagopal, Apoorva
AU - Pons, Jose L.
AU - Delp, Scott
N1 - Funding Information:
SD is supported by the US National Institutes of Health grants P2CHD101913 and P41EB027060 . JP is supported by the EU grant agreement no. 779982 .
Publisher Copyright:
© 2022
PY - 2022/4/15
Y1 - 2022/4/15
N2 - Pathological tremor in patients with essential tremor and Parkinsons disease is typically treated using medication or neurosurgical interventions. There is a widely recognized need for new treatments that avoid the side effects of current medications and do not carry the risks of surgical interventions. Building on decades of research and engineering development, non-invasive electrical stimulation of peripheral nerves has emerged as a safe and effective strategy for reducing pathologic tremor in essential tremor. This review surveys the peripheral electrical stimulation (PES) literature and summarizes effectiveness, safety, clinical translatability, and hypothesized tremor-reduction mechanisms of various PES approaches. The review also proposes guidelines for assessing tremor in the context of evaluating new therapies that combine the strengths of clinician assessments, patient evaluations, and novel motion sensing technology. The review concludes with a summary of future directions for PES, including expanding clinical access for patients with Parkinson's disease and leveraging large, at-home datasets to learn more about tremor physiology and treatment effect that will better characterize the state of tremor management and accelerate discovery of new therapies. Growing evidence suggests that non-invasive electrical stimulation of afferent neural pathways provides a viable new option for management of pathological tremor, with one specific PES therapy cleared for prescription and home use, suggesting that PES be considered along with medication and neurosurgical interventions for treatment of tremor. This article is part of the Special Issue “Tremor” edited by Daniel D. Truong, Mark Hallett, and Aasef Shaikh.
AB - Pathological tremor in patients with essential tremor and Parkinsons disease is typically treated using medication or neurosurgical interventions. There is a widely recognized need for new treatments that avoid the side effects of current medications and do not carry the risks of surgical interventions. Building on decades of research and engineering development, non-invasive electrical stimulation of peripheral nerves has emerged as a safe and effective strategy for reducing pathologic tremor in essential tremor. This review surveys the peripheral electrical stimulation (PES) literature and summarizes effectiveness, safety, clinical translatability, and hypothesized tremor-reduction mechanisms of various PES approaches. The review also proposes guidelines for assessing tremor in the context of evaluating new therapies that combine the strengths of clinician assessments, patient evaluations, and novel motion sensing technology. The review concludes with a summary of future directions for PES, including expanding clinical access for patients with Parkinson's disease and leveraging large, at-home datasets to learn more about tremor physiology and treatment effect that will better characterize the state of tremor management and accelerate discovery of new therapies. Growing evidence suggests that non-invasive electrical stimulation of afferent neural pathways provides a viable new option for management of pathological tremor, with one specific PES therapy cleared for prescription and home use, suggesting that PES be considered along with medication and neurosurgical interventions for treatment of tremor. This article is part of the Special Issue “Tremor” edited by Daniel D. Truong, Mark Hallett, and Aasef Shaikh.
KW - Afferent pathways
KW - Essential tremor
KW - Neuromodulation
KW - Parkinson's disease
KW - Pathological tremor
KW - Tremor treatment
UR - http://www.scopus.com/inward/record.url?scp=85125199568&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125199568&partnerID=8YFLogxK
U2 - 10.1016/j.jns.2022.120195
DO - 10.1016/j.jns.2022.120195
M3 - Review article
C2 - 35220113
AN - SCOPUS:85125199568
SN - 0022-510X
VL - 435
JO - Journal of the Neurological Sciences
JF - Journal of the Neurological Sciences
M1 - 120195
ER -